NCT07311603 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07311603
Title	Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Indications	head and neck squamous cell carcinoma triple-receptor negative breast cancer Advanced Solid Tumor ovary epithelial cancer pancreatic ductal adenocarcinoma lung non-small cell carcinoma stomach cancer
Therapies	M7437
Age Groups:	senior \| adult
Covered Countries	DEU

NCT07311603
Clinical Trial Detail